HOC is our outreach and engagement site which connects us with healthcare professionals, industry personnel and academics worldwide.
Our HOC platform shares blogs from experienced medical writers around the world, bringing you tips on good communication, evaluations of current health economics and outcomes research and healthcare evidence. Mixed in with great information you will find a light-hearted approach to current issues, some valuable downloads, as well as references for further reading.
We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers what can health economics and outcomes researchers gain from leveraging the expertise within the medical publications arena to better communicate the value of their research?
Details
The power of a graph lies in its ability to convey a variety of complex relationships in a way that is difficult to describe in words, but is easily comprehended from a picture.
Details
Information is an important part of the patient journey and central to the overall quality of each patient’s experience with your drug, treatment or product. To help you get…
Details
As part of FREE Patient Education Material offer we have written this post to showcase some of the best examples of patient education websites on the web to help you…
Details
We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers what they thought were the key motivations for health economics and outcomes researchers working together with medical publications professionals?
Details
We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers What type of collaborative initiatives are currently emerging within the medical publications and pharmaceutical arena?
Details
Regionalisation of phase IV trials because of payer differences sounds like a good thing in the short term. Improved market access, for one. But has anyone considered the longer term effects?
Details
Interesting article in PharmaVoice in April 2012 – regarding Competitive Intelligence and Competitor Strategy. The article rightly points out that Pharma is leaving good intel on the table –by not…
Details
As noted by our former editor, David Woods, euphemisms have been referred to as verbal placebos – a way of discussing unpleasant topics in a more palatable manner. But do euphemisms really change the way we think? And should Health economists be encouraged to use them when discussing their economics research of medical topics?
Details
Ruairi O’Donnell writes in the March 2012 issue of Pharmaceutical Market Europe that evidence matters. Of course it does. And particularly in market access activities, which is the context he…
Details
